REMEDUS
ActiveSummary
REMEDUS has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €463,351 and a net result of €736,403. Equity is shrinking by ~14.7% per year across the filed fiscal years. Its solvency ranks better than 17% of 646 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability80▲+19
Solvency36▲+1
Growth56▲+16
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25,000 at 30 days acceptable
Liquidity short (current ratio 0.87 against 0.9 in 2024; short-term debt: 86.8% and cash: 10.3% of total assets), and 89.1% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
10.9%
Return on assets
17.3%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 646 sector peers (2025).
NBB · sector comparisonPosition among 646 sector peers
Solvency
better than 17%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
24 d early
2024
105 d late
2023
155 d late
2022
301 d late
2021
19 d early
2021
40 d early
2020
114 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 85 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 13 November (4 of the last 5 filed years within 129 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
In the rankings
#7 company by total assets in Kontich, Health and social work sector#8 oldest company in Kontich, Health and social work sector#9 company by staff growth in the province of Antwerp, Human health sector
Turnover
€16.7m▲ 6.2%
2024 · €15.7m
EBIT margin
6.6%▲ 5.2pp
2024 · 1.4%
Net result
€736,403▲ 424%
2024 · €140,636
Working capital
-€461,471▲ 1.1%
2024 · -€466,374
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€6.3m-€13.0m▲ 107%€14.2m▲ 9.6%€15.7m▲ 10.5%€16.7m▲ 6.2%
Operating result€1.5m-€2.1m▲ 37.2%€683,956▼ 67.3%€222,739▼ 67.4%€1.1m▲ 395%
Net result€1.5mabove the sector's middle half-€1.6mabove the sector's middle half▲ 11.4%€538,870above the sector's middle half▼ 67.2%€140,636within the sector's middle half▼ 73.9%€736,403above the sector's middle half▲ 424%
EBIT margin24.3%-16.1%▼ 8.2pp4.8%▼ 11.3pp1.4%▼ 3.4pp6.6%▲ 5.2pp
Equity€505,674within the sector's middle half-€1.4mabove the sector's middle half▲ 186%€1.2mabove the sector's middle half▼ 18.0%€526,948within the sector's middle half▼ 55.6%€463,351within the sector's middle half▼ 12.1%
Total assets€4.1mabove the sector's middle half-€5.1mabove the sector's middle half▲ 26.2%€5.3mabove the sector's middle half▲ 4.0%€5.3mabove the sector's middle half▲ 0.1%€4.2mabove the sector's middle half▼ 20.4%
Debt€3.6m-€3.7m▲ 3.4%€4.1m▲ 12.7%€4.8m▲ 16.1%€3.8m▼ 21.3%
Working capital-€266,509below the sector's middle half-€509,751above the sector's middle half€507below the sector's middle half▼ 99.9%-€466,374below the sector's middle half-€461,471below the sector's middle half▲ 1.1%
Solvency12.5%below the sector's middle half-28.2%within the sector's middle half▲ 15.8pp22.3%below the sector's middle half▼ 6.0pp9.9%below the sector's middle half▼ 12.4pp10.9%below the sector's middle half▲ 1.0pp
Current ratio0.92below the sector's middle half-1.15within the sector's middle half▲ 0.231.00below the sector's middle half▼ 0.150.90below the sector's middle half▼ 0.100.87below the sector's middle half▼ 0.02
Return on assets (ROA)36.3%above the sector's middle half-32.0%above the sector's middle half▼ 4.3pp10.1%within the sector's middle half▼ 21.9pp2.6%below the sector's middle half▼ 7.5pp17.3%within the sector's middle half▲ 14.7pp
Staff (FTE)55above the sector's middle half-51.7above the sector's middle half▼ 6.0%57.7above the sector's middle half▲ 11.6%60.8above the sector's middle half▲ 5.4%64.6above the sector's middle half▲ 6.3%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Why a figure moved sharply
- 2022 Turnover +107% on 2021. The previous fiscal year ran 6 months, this one 12.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 395% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.2m
Fixed assets
€1.0m ▼ 24.1%
Current assets
€3.2m ▼ 19.2%
Equity and liabilities €4.2m
Equity
€463,351 ▼ 12.1%
Debt
€3.8m ▼ 21.3%
Debt's share of the balance-sheet total falls from 90.1% to 89.1%. Equity and debt are lower.
Key figures and ratios
EBITDA
€1.6m▲
2024 · €768,613
Cash flow
€1.3m▲
2024 · €686,510
Quick ratio
0.72▼
2024 · 0.79
Debt to equity
8.17▼
2024 · 9.13
ROE
158.9%▲
2024 · 26.7%
Interest coverage
99.38▲
2024 · 83.73
Debt ≤ 1 year
€3.7m▼
2024 · €4.5m
Income taxes
€347,519▲
2024 · €70,471
Staff costs
€5.2m▲
2024 · €4.7m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 378 companies that looked in July 2024 the way this one looks now, 0.3% went bankrupt within 24 months and 97% are still going.
- Medium-sized
- 20 years or older
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
0.3%
went bankrupt
2.4%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 378 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | €7.4m | €13.2m | €14.4m | €15.8m | €17.4m | ▲ 10.4% |
| Turnover70 | €6.3m | €13.0m | €14.2m | €15.7m | €16.7m | ▲ 6.2% |
| Other operating income74 | €175,580 | €220,376 | €158,500 | €31,754 | €691,627 | ▲ 2,078% |
| Non-recurring operating income76A | €970,691 | €0 | - | €145 | €1 | ▼ 99.2% |
| Operating charges60/66A | €5.9m | €11.1m | €13.7m | €15.5m | €16.3m | ▲ 4.8% |
| Goods for resale, raw materials and consumables60 | €2.0m | €3.8m | €5.0m | €6.2m | €6.5m | ▲ 4.6% |
| Purchases600/8 | €2.0m | €4.0m | €5.0m | €6.1m | €6.6m | ▲ 7.5% |
| Change in stocks: decrease (increase)609 | €15,718 | -€195,702 | -€13,937 | €43,222 | -€130,510 | ▼ 402% |
| Services and other goods61 | €2.0m | €3.6m | €4.4m | €4.0m | €3.9m | ▼ 3.1% |
| Remuneration, social security and pensions62 | €1.6m | €3.4m | €3.9m | €4.7m | €5.2m | ▲ 12.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €136,690 | €313,066 | €409,647 | €545,874 | €518,264 | ▼ 5.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | €180,000 | -€50,000 | €0 | €78,845 | €112,643 | ▲ 42.9% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | -€30,000 | - | - | - | - | - |
| Other operating charges640/8 | €6,446 | €8,039 | €18,816 | €10,149 | €29,439 | ▲ 190% |
| Operating profit (loss)9901 | €1.5m | €2.1m | €683,956 | €222,739 | €1.1m | ▲ 395% |
| Financial income75/76B | €87 | €821 | €0 | €294 | €0 | ▼ 100% |
| Recurring financial income75 | €87 | €821 | €0 | €294 | €0 | ▼ 100% |
| Other financial income752/9 | €87 | €821 | €0 | €294 | €0 | ▼ 100% |
| Financial charges65/66B | €3,319 | €10,472 | €2,453 | €11,925 | €19,251 | ▲ 61.4% |
| Recurring financial charges65 | €3,319 | €10,472 | €2,453 | €11,925 | €19,251 | ▲ 61.4% |
| Debt charges650 | €236 | €4,499 | €489 | €9,180 | €16,316 | ▲ 77.7% |
| Other financial charges652/9 | €3,082 | €5,973 | €1,964 | €2,745 | €2,935 | ▲ 6.9% |
| Profit (loss) for the period before taxes9903 | €1.5m | €2.1m | €681,503 | €211,107 | €1.1m | ▲ 413% |
| Income taxes67/77 | €47,998 | €441,139 | €142,632 | €70,471 | €347,519 | ▲ 393% |
| Taxes670/3 | €47,998 | €441,139 | €142,632 | €70,471 | €347,519 | ▲ 393% |
| Profit (loss) for the period9904 | €1.5m | €1.6m | €538,870 | €140,636 | €736,403 | ▲ 424% |
| Profit (loss) for the period to be appropriated9905 | €1.5m | €1.6m | €538,870 | €140,636 | €736,403 | ▲ 424% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €4.1m | €5.1m | €5.3m | €5.3m | €4.2m | ▼ 20.4% |
| Fixed assets21/28 | €970,825 | €1.2m | €1.3m | €1.3m | €1.0m | ▼ 24.1% |
| Intangible fixed assets21 | €3,884 | €203,230 | €331,435 | €326,259 | €192,204 | ▼ 41.1% |
| Tangible fixed assets22/27 | €966,892 | €981,261 | €1.0m | €1.0m | €830,175 | ▼ 18.6% |
| Plant, machinery and equipment23 | €599,670 | €691,663 | €753,591 | €762,499 | €622,328 | ▼ 18.4% |
| Furniture and vehicles24 | €287,626 | €211,401 | €123,132 | €76,316 | €45,389 | ▼ 40.5% |
| Other tangible fixed assets26 | €79,597 | €70,124 | €60,772 | €181,524 | €162,458 | ▼ 10.5% |
| Assets under construction and advance payments27 | - | €8,073 | €77,456 | €0 | - | - |
| Financial fixed assets28 | €50 | €50 | €50 | €0 | - | - |
| Other financial fixed assets284/8 | €50 | €50 | €50 | €0 | - | - |
| Amounts receivable and cash guarantees285/8 | €50 | €50 | €50 | €0 | - | - |
| Current assets29/58 | €3.1m | €3.9m | €4.0m | €4.0m | €3.2m | ▼ 19.2% |
| Stocks and contracts in progress3 | €290,202 | €485,905 | €499,842 | €456,620 | €587,129 | ▲ 28.6% |
| Stocks30/36 | €290,202 | €485,905 | €499,842 | €456,620 | €587,129 | ▲ 28.6% |
| Goods purchased for resale34 | €290,202 | €485,905 | €499,842 | €456,620 | €587,129 | ▲ 28.6% |
| Amounts receivable within one year40/41 | €1.2m | €1.9m | €1.5m | €2.0m | €2.1m | ▲ 8.6% |
| Trade receivables40 | €1.2m | €1.5m | €1.4m | €1.8m | €2.1m | ▲ 18.0% |
| Other amounts receivable41 | €1,120 | €329,013 | €100,835 | €157,036 | €0 | ▼ 100% |
| Cash at bank and in hand54/58 | €1.6m | €1.5m | €1.8m | €1.5m | €437,125 | ▼ 71.3% |
| Deferred charges and accrued income490/1 | - | €90,924 | €239,971 | €40,708 | €63,304 | ▲ 55.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €4.1m | €5.1m | €5.3m | €5.3m | €4.2m | ▼ 20.4% |
| Equity10/15 | €505,674 | €1.4m | €1.2m | €526,948 | €463,351 | ▼ 12.1% |
| Contributions10/11 | €18,592 | €18,592 | €18,592 | €18,592 | €18,592 | = |
| Reserves13 | €28,512 | €28,512 | €28,512 | €28,512 | €28,512 | = |
| Non-distributable reserves130/1 | €1,859 | €1,859 | €1,859 | €1,859 | €1,859 | = |
| Reserves not available under the articles1311 | €1,859 | €1,859 | €1,859 | €1,859 | €1,859 | = |
| Tax-exempt reserves132 | €26,652 | €26,652 | €26,652 | €26,652 | €26,652 | = |
| Profit (loss) carried forward14 | €458,570 | €1.4m | €1.1m | €479,845 | €416,248 | ▼ 13.3% |
| Amounts payable17/49 | €3.6m | €3.7m | €4.1m | €4.8m | €3.8m | ▼ 21.3% |
| Amounts payable after more than one year17 | €40,210 | €25,260 | €0 | - | - | - |
| Financial debts170/4 | €40,210 | €25,260 | €0 | - | - | - |
| Credit institutions173 | €40,210 | €25,260 | €0 | - | - | - |
| Amounts payable within one year42/48 | €3.4m | €3.4m | €4.0m | €4.5m | €3.7m | ▼ 17.3% |
| Current portion of amounts payable after more than one year42 | €14,796 | €14,949 | €0 | - | - | - |
| Trade debts44 | €1.0m | €963,254 | €1.5m | €1.8m | €2.0m | ▲ 9.4% |
| Suppliers440/4 | €1.0m | €963,254 | €1.5m | €1.8m | €2.0m | ▲ 9.4% |
| Taxes, remuneration and social security45 | €623,428 | €1.6m | €835,366 | €850,032 | €697,980 | ▼ 17.9% |
| Taxes450/3 | €102,334 | €878,031 | €187,738 | €134,574 | €152,002 | ▲ 13.0% |
| Remuneration and social security454/9 | €521,093 | €718,194 | €647,628 | €715,458 | €545,978 | ▼ 23.7% |
| Other amounts payable47/48 | €1.7m | €856,012 | €1.7m | €1.8m | €980,362 | ▼ 44.6% |
| Accrued charges and deferred income492/3 | €158,433 | €221,589 | €160,630 | €353,276 | €97,558 | ▼ 72.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €1.5m | €1.6m | €538,870 | €140,636 | €736,403 | ▲ 424% |
| + Depreciation and write-downs630 | €136,690 | €313,066 | €409,647 | €545,874 | €518,264 | ▼ 5.1% |
| Operating cash flow (approximation) | €1.6m | €2.0m | €948,517 | €686,510 | €1.3m | ▲ 82.8% |
| Investment in fixed assets (approximation) | - | -€526,782 | -€571,541 | -€546,037 | -€194,045 | ▲ 64.5% |
| Change in cash | - | -€119,137 | €260,062 | -€246,184 | -€1.1m | ▼ 341% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
13-11
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 105 days late
02-01
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 155 days late
2024
31-12
Financial
Weakest financial yearnet €140,636 ▼73.9%
Net result drops to €140,636, the lowest in the series; recovery starts the following year.
27-05
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 301 days late
2022
31-12
Financial
Highest result since 2019net €1.6m ▲11.4%
Operating result €2.1m, net result €1.6m, both a record.
31-12
Financial
Equity above €1mEq €1.4m ▲186%
5 profitable years in a row build equity to €1.4m.
12-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
22-12
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
25-05
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 114 days late
2020
21-01
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
10-01
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
12-01
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 15 acts read
About the unread acts
We know of 15 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 15 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Kontich · 1 establishment unit since 1996
Ground area
435 m²
Parcel 11024G0007/00E000, Flanders. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
REMEDUS
since 19962.074.564.041
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11024G0007/00E000 | Flanders | 435 m² | - | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 ownerChain of control
- Mediq International BVNL
- MEDECO
- REMEDUS
Highest known parent: Mediq International BV (Netherlands). The sources do not say who stands above it.
Owners 1
- MEDECOparentSourceaccounts MEDECO 2025100%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Subsidies and aid
Flemish government
2022 to 2025 · 7 entries · 19,742 EUR awarded · 19,741 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 3,395 EUR | 5,203 EUR |
| 2024 | 2 | 1,809 EUR | 140 EUR |
| 2023 | 2 | 3,639 EUR | 7,835 EUR |
| 2022 | 2 | 10,899 EUR | 6,563 EUR |
Recognitions · licences · registrations
Food safety, FASFC
1 siteKontich2.074.564.041
Legal Entity Identifier
699400SDKA06H54K0G76
Similar companies · same sector, comparable size
RHUMATO P.M.
BE 0463.370.285
Sint-Lambrechts-Woluwe · Eq €463,111
DOKTER DILLEN Koen
BE 0824.894.829
Mol · Eq €460,524
GEPCO
BE 0681.734.410
Wemmel · Eq €466,218
Kinepraktijk Buckinx
BE 0834.291.159
Tongeren-Borgloon · Eq €466,437
VISTA Consulting
BE 0894.303.772
Duffel · Eq €460,193
Of 10,428 companies in this sector we hold annual accounts for 885. 520 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded21-12-1995
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
86995Nutrition and dietetics services
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
E-invoicing
Reachable via Peppol
Peppol ID
0208:0456716679
Also
9925:BE0456716679
Registered
27-03-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.